Amends the Federal Food, Drug, and Cosmetic Act to require drug labels to disclose active and inactive ingredients. (Under current law, generally only active ingredients are required to be disclosed.)
Introduced in House
Introduced in House
Referred to House Committee on Energy and Commerce.
Referred to Subcommittee on Health and the Environment.
Subcommittee Hearings Held.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line